Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, Augu... (w. Contacts: Jack Lief ...)

(Date:12/3/2009)... Dec. 3 ACCESS PHARMAC...ay provided an update on its European commercial l...l mucositis, a debilitating side effect of radiati...lly launched by Access, partner, SpePharm, in six ...ly, Norway, Greece and Sweden. Access is conductin...

(Date:12/3/2009)..., Dec. 3 Shire plc (LSE:...armaceutical company, today announced a voluntary ...l of one lot of the Attention-Deficit/Hyperactivit... taking this action because some Daytrana patches ...lease liner removal specification, and as a result...

(Date:12/3/2009)...s., Dec. 3 Inverness Med...ader in enabling individuals to take charge of the...nostics and health management, has declared a divi...e Perpetual Preferred Stock ( IMA-PB). The dividen...mount per share equal to the quotient of (a) $3.00...

(Date:12/3/2009)...EW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. S...Shenzhen Beike Biotechnology Co. Ltd.,( http://www...h-Risk Diabetic,Foot Care in New Delhi, India, Nov... research and regenerative medicine company. ,,...atry Association (IPA), aimed,to help podiatrists ...

Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2 Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3 Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4 Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2 Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3 Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4 Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5 Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2 Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3

[0] Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe [0] Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced [0] Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock [0] Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India

...LE, Md., Sept. 4 Human Genome,Sciences, Inc. (Nas... at the,BioCentury - Thomson Financial 14th Annive...e will be webcast and may be accessed at, http://w...-bin/prnh/20010612/HGSLOGO ) A member of Human G...t,an overview of the company on Thursday, Septembe...

...STER, Colo., Sept. 4 Allos,Therapeutics, Inc. (Na... on,the development and commercialization of small..., today announced that Paul L. Berns, President an...ar Stearns 20th Annual,Healthcare Conference in Ne...e at 9:00 a.m. (Eastern) on,Monday, September 10, ...

...reas Krause to Present on Statistical Consideratio...to Present on Modeling and Simulation ...lif., Sept. 4 Pharsight,Corporation (OTC Bulletin...strategic services for optimizing clinical drug de...cientists will deliver two presentations,to biopha...

Other Biology Technology:Allos Therapeutics to Present at the Bear Stearns 20th Annual Healthcare Conference 2 Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007 2 Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007 3

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference Allos Therapeutics to Present at the Bear Stearns 20th Annual Healthcare Conference Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007

(Date:12/3/2009)...QUE, N.M. Most scientists believe that staph infe...nal each other to emit toxins. The signaling proce...must be present to start the process. , But the ...e very first stage of staph infection, when bacter...rs in a single cell and that this individual proce...

(Date:12/3/2009)... fish can undergo a personality change in warmer w...ing that climate change may make some species more...oung damselfish on Australia,s Great Barrier Reef ...are either consistently timid, or consistently bol...more marked as water temperatures rise. , A slig...

(Date:12/3/2009)...llers must be included in the design of the upcomi...umanitarian crisis, according to a scientist at th...re , Dr Simon Lewis argues that at least 50% of th...n, known as REDD (Reducing Emissions from Deforest...wellers directly, and their property rights assure...

Breaking Biology News(10 mins):Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2 Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3 Fish with attitude: Some like it hot 2 Forest deal at Copenhagen must avoid creating 'carbon refugees' 2 Gen Probe to Acquire Prodesse Leader in Molecular Testing for Respiratory Infectious Diseases for 2460 Million in Cash Plus Potential Milestone Pay 14377 1 Gen Probe to Acquire Prodesse Leader in Molecular Testing for Respiratory Infectious Diseases for 2460 Million in Cash Plus Potential Milestone Pay 14377 2 Gen Probe to Acquire Prodesse Leader in Molecular Testing for Respiratory Infectious Diseases for 2460 Million in Cash Plus Potential Milestone Pay 14377 3 Gen Probe to Acquire Prodesse Leader in Molecular Testing for Respiratory Infectious Diseases for 2460 Million in Cash Plus Potential Milestone Pay 14377 4 Gen Probe to Acquire Prodesse Leader in Molecular Testing for Respiratory Infectious Diseases for 2460 Million in Cash Plus Potential Milestone Pay 14377 5 Medco Announces Date for Third Quarter 2009 Financial Results 3B Company to Provide 2010 Earnings Guidance 5273 1 Medco Announces Date for Third Quarter 2009 Financial Results 3B Company to Provide 2010 Earnings Guidance 5273 2 High sensitivity bone marrow aspiration technology enhances leukemia cell detection 58991 1 High sensitivity bone marrow aspiration technology enhances leukemia cell detection 58991 2

[0] Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find [0] Fish with attitude: Some like it hot [0] Forest deal at Copenhagen must avoid creating 'carbon refugees'

... worlds leading STM publishers, will publish the J...l publication of the EUCC the Coastal Union. Lin...n to Springers other journals in coastal science, ...w and Marine Biology. The first issue of the rela... revised and broadened orientation and new subtitl...

...reporting what they say is a significant improveme...mouse cells to their embryonic state, a process th...c stem cells. , The finding, published on-line as...(Sept. 6, 2007), builds on the strategic breakthro... and confirmed in the spring of 2007 both by Yaman...

... Lodge, and Jennifer Hsia (University of Notre Dam... research communication, Failure of the Lacey Act ... The study appears in the September issue of Fron... 100 years on the books (passed in 1900), the Lace...nimal species. The injurious wildlife provision o...

Other Biology News:Springer will publish Journal of Coastal Conservation 2 Embryonic stem cell strategy advanced with UCSF finding 2 Embryonic stem cell strategy advanced with UCSF finding 3 Embryonic stem cell strategy advanced with UCSF finding 4 Examining the Lacey Act 2

Springer will publish Journal of Coastal Conservation Embryonic stem cell strategy advanced with UCSF finding Examining the Lacey Act

NucBuster Protein Extraction Kit from Novagen

Goat IgG, Unconjugated from CHEMICON

DETACHaBEAD Mouse CD4 from Dynal Biotech

Rabbit anti-USP33 AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories

Biology Products:

NucBuster Protein Extraction Kit from Novagen Goat IgG, Unconjugated from CHEMICON DETACHaBEAD Mouse CD4 from Dynal Biotech Rabbit anti-USP33 AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories

Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, Augu...(w. Contacts: Jack Lief ...)